Related Experiment Video
Updated: Jun 17, 2025
04:08
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
2.8K
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Ellen Hertz1, Yu Chen1, Ellen Sidransky2
1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Nature Reviews. Neurology
|August 6, 2024
Summary
Parkinson disease (PD) is linked to Gaucher disease, a rare genetic disorder caused by GBA1 mutations. Understanding this connection highlights lysosomal pathways
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Gaucher disease is a lysosomal storage disorder due to glucocerebrosidase deficiency, encoded by the GBA1 gene.
- Parkinson disease (PD) shows a higher incidence in individuals with Gaucher disease and carriers of GBA1 mutations.
- A significant percentage of PD patients (3-25%) carry GBA1 variants, though penetrance is low.
Purpose of the Study:
- To explore the association between Gaucher disease and Parkinson disease.
- To investigate the role of glucocerebrosidase deficiency in PD pathogenesis.
- To understand the underlying mechanisms of GBA1-related PD.
Main Methods:
- Clinical and radiological evaluations.
- Genetic studies.
- Investigations using model systems.
Main Results:
- Established a link between GBA1 mutations and increased PD risk.
- Identified glucocerebrosidase deficiency as a potential factor in PD pathogenesis.
- Highlighted the role of lysosomal pathways in parkinsonism.
Conclusions:
- The association between Gaucher disease and PD underscores the importance of lysosomal dysfunction in neurodegeneration.
- Insights from Gaucher disease therapeutics may inform PD drug development.
- Further research is needed to elucidate the precise mechanisms of GBA1-PD.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
01:24Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
541
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
541